| Literature DB >> 35022067 |
Tosca O E de Crom1, Sanne S Mooldijk2, M Kamran Ikram2,3, M Arfan Ikram2, Trudy Voortman2,4.
Abstract
BACKGROUND: Adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet has been linked to a decreased risk of dementia, but reverse causality and residual confounding by lifestyle may partly account for this link. We aimed to address these issues by studying the associations over cumulative time periods, which may provide insight into possible reverse causality, and by using both historical and more contemporary dietary data as this could give insight into confounding since historical data may be less affected by lifestyle factors.Entities:
Keywords: Dementia; Dietary pattern; Epidemiology; MIND diet; Population-based
Mesh:
Year: 2022 PMID: 35022067 PMCID: PMC8756695 DOI: 10.1186/s13195-022-00957-1
Source DB: PubMed Journal: Alzheimers Res Ther Impact factor: 6.982
Characteristics of the study population at baselines I and II
| Baseline I (between 1989 and 1993) ( | Baseline II (between 2009 and 2012) ( | |
|---|---|---|
| 3169 (59.0) | 1643 (57.4) | |
| 67.7 ± 7.8 | 75.3 ± 5.9 | |
| Primary | 1102 (20.6) | 192 (6.8) |
| Lower | 2281 (42.6) | 1215 (43.3) |
| Intermediate | 1504 (28.1) | 930 (33.1) |
| Higher | 463 (8.7) | 469 (16.7) |
| Never | 1800 (33.7) | 914 (32.0) |
| Former | 2296 (43.0) | 1667 (58.4) |
| Current | 1247 (23.3) | 274 (9.6) |
| 26.3 ± 3.6 | 27.4 ± 4.2 | |
| 83.4 ± 43.9 | 50.0 ± 45.4 | |
| 1974 ± 499 | 1994 ± 658 | |
| 357 (6.9) | 418 (15.2) | |
| 3602 (67.1) | 1549 (56.1) | |
| 3202 (59.8) | 2461 (87.0) | |
| 314 (18.7) | 713 (15.7) | |
| 98 (1.8) | 145 (5.1) | |
| 1416 (27.5) | 703 (26.1) | |
| MIND diet | 5.9 ± 1.3 (2.0–11.5) | 7.4 ± 1.6 (1.5–13.5) |
| Dutch dietary guidelines | 6.8 ± 1.8 (1–13) | 6.8 ± 1.8 (1–13) |
| Mediterranean diet | 36.7 ± 3.3 (20–47) | 37.1 ± 4.1 (19–51) |
Data are shown for non-imputed data and are presented as mean ± standard deviation for continuous variables and number (percentages) for categorical variables unless stated otherwise
Abbreviations: APOE Apolipoprotein E, MET Metabolic equivalent of task, MIND Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay; N, total number of participants
Diet scores in association with the risk of all-cause dementia
| Hazard ratio (95% confidence interval) | ||||
|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||
| 1188/5375 | ||||
| MIND diet score | 0.99 (0.93–1.05) | 1.00 (0.94–1.06) | 0.99 (0.94–1.05) | |
| Dutch dietary guidelines score | 1.01 (0.95–1.07) | 1.01 (0.96–1.07) | 1.01 (0.96–1.07) | |
| Mediterranean diet score | 1.03 (0.97–1.10) | 1.04 (0.98–1.10) | 1.04 (0.97–1.10) | |
| 248/2861 | ||||
| MIND diet score | 0.79 (0.70–0.90) | 0.80 (0.70–0.91) | 0.79 (0.70–0.91) | |
| Dutch dietary guidelines score | 0.88 (0.78–1.00) | 0.90 (0.79–1.02) | 0.89 (0.78–1.02) | |
| Mediterranean diet score | 0.76 (0.67–0.86) | 0.76 (0.66–0.86) | 0.75 (0.66–0.86) | |
Hazard ratios are per standard deviation increase in diet score. Model 1 is adjusted for sex, age, age^2, and educational attainment. Model 2 is further adjusted for smoking status, physical activity, and daily energy intake. Model 3 is further adjusted for body mass index, diabetes, hypercholesterolemia, and hypertension
Abbreviations: MIND Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay, n number of participants with incident all-cause dementia; N, total number of participants
Fig. 1Diet scores in association with the risk of all-cause dementia, per cumulative follow-up interval. Hazard ratios are per standard deviation increase in diet score and adjusted for sex, age, age^2, educational attainment, smoking status, physical activity, and daily energy intake. MIND, Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay
Fig. 2Subgroup and sensitivity analyses for the MIND diet score in association with the risk of all-cause dementia. Hazard ratios are per standard deviation increase in diet score and adjusted for sex, age, age^2, educational attainment, smoking status, physical activity, and daily energy intake. p for APOE ɛ 4 carrier status interaction 0.108 for baseline I and 0.005 for baseline II. APOE, apolipoprotein E; MIND, Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay; MMSE, Mini-Mental State Examination; n, number of participants with incident dementia; N, total number of participants